Autoimmune Skin Conditions: Psoriasis

FP Essent. 2023 Mar:526:7-12.

Abstract

Psoriasis is a chronic, inflammatory skin condition with significant effect on quality of life. It affects 3.2% of the United States population. Psoriasis is caused by an interaction between genetic and environmental triggers. Associated conditions include depression, increased cardiovascular risk, hypertension, hyperlipidemia, diabetes, nonalcoholic fatty liver disease, Crohn disease, ulcerative colitis, celiac disease, nonmelanoma skin cancers, and lymphoma. Several clinical variants exist, including chronic plaque, guttate, pustular, inverse, and erythrodermic psoriasis. Lifestyle modification and topical therapies, such as emollients, coal tar, topical corticosteroids, vitamin D analogues, and calcineurin inhibitors, are used for limited disease. More severe psoriasis may require systemic therapy with oral or biologic therapy. Individualized management of psoriasis may involve different combinations of treatments. Counseling patients about associated comorbidities is essential.

MeSH terms

  • Comorbidity
  • Glucocorticoids / therapeutic use
  • Humans
  • Psoriasis* / drug therapy
  • Psoriasis* / therapy
  • Quality of Life*
  • United States
  • Vitamin D / therapeutic use

Substances

  • Glucocorticoids
  • Vitamin D